Clinical trial

Vaccine and Antibody Treatment of Prostate Cancer

NCT00113984

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention PROSTVAC-V/TRICOM Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention PROSTVAC-F/TRICOM Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention MDX-010 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Sargramostim Normalized identity: sargramostimView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Vaccine and Antibody Treatment of Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-06-08

PhasePHASE1

Conditions

Prostatic Neoplasmsunresolved

Interventions

PROSTVAC-V/TRICOMBIOLOGICAL

PROSTVAC-F/TRICOMBIOLOGICAL

MDX-010DRUG

SargramostimDRUG · verified · RxNorm: sargramostim

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00113984 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.